Abstract:The mechanism of SENPs involved in human oxidative stress‐related diseases. Oxidative stress is employed to depict a series of responses detrimental to normal cellular functions resulting from an imbalance between intracellular oxidants, mainly reactive oxygen species and antioxidant defenses. Oxidative stress often contributes to the development of various diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. In this process, the relationship between small ubiquitin‐like modifier (SUMO) and oxidative stress has garnered significant attention, with its posttranslational modification (PTM) frequently serving as a marker of oxidative stress status. Sentrin/SUMO‐specific proteases (SENPs), affected by alternative splicing, PTMs such as phosphorylation and ubiquitination, and various protein interactions, are crucial molecules in the SUMO process. The human SENP family has six members (SENP1–3, SENP5–7), which are classified into two categories based on sequence similarity, substrate specificity, and subcellular location. They have two core functions in the human body: first, by cleaving the precursor SUMO and exposing the C‐terminal glycine, they initiate the SUMO process; second, they can specifically recognize and dissociate SUMO proteins bound to substrates, a process known as deSUMOylation. However, the connection between deSUMOylation and oxidative stress remains a relatively unexplored area despite their strong association with oxidative diseases such as cancer and cardiovascular disease. This article aims to illustrate the significant contribution of SENPs to the oxidative stress pathway through deSUMOylation by reviewing their structure and classification, their roles in oxidative stress, and the changes in their expression and activity in several typical oxidative stress‐related diseases.

Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway

Desumoylase Senp6 Maintains Osteochondroprogenitor Homeostasis By Suppressing The P53 Pathway (Vol 9, 2018)

Pten is Necessary for the Quiescence and Maintenance of Adult Muscle Stem Cells

Hsp90β Interacts with MDM2 to Suppress P53‐dependent Senescence During Skeletal Muscle Regeneration

Publisher Correction: Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway

Premature Aging of Skeletal Stem/progenitor Cells Rather Than Osteoblasts Causes Bone Loss with Decreased Mechanosensation.

SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity

SENP1 Is a Crucial Regulator for Cell Senescence through DeSUMOylation of Bmi1

An Essential Role of Small Ubiquitin-like Modifier (Sumo)-Specific Protease 2 in Myostatin Expression and Myogenesis*

Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction

SENP3 Suppresses Osteoclastogenesis by De-conjugating SUMO2/3 from IRF8 in Bone Marrow-Derived Monocytes.

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

Impaired mitochondrial oxidative metabolism in skeletal progenitor cells leads to musculoskeletal disintegration

SHP2 ablation mitigates osteoarthritic cartilage degeneration by promoting chondrocyte anabolism through SOX9

Programmed Cell Senescence in Skeleton During Late Puberty.

Myeloid SENP3 deficiency protects mice from diet and age-induced obesity via regulation of YAP1 SUMOylation

The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence

Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology

Sumo-Specific Protease 1 Is Critical For Myeloid-Derived Suppressor Cell Development And Function

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

SIRT6 Delays Cellular Senescence by Promoting P27kip1 Ubiquitin-Proteasome Degradation.